Results 211 to 220 of about 6,570,481 (314)

Effectiveness of a 5G Local Area Network-Based Digital Microscopy Interactive System: Quasi-Experimental Design.

JMIR Med Educ
Xu J, Sha J, Jia S, Li J, Xu L, Shao Z.
europepmc   +1 more source

Comparative analysis of commercial human primary mesangial cell, implications for experimental design. [PDF]

BMC Nephrol
Johansson A, Narasimhan G, Keuenhof K, Boi R, Ebefors K.   +4 more
europepmc   +1 more source

Design and experimental investigation of a large diameter electron cyclotron resonant plasma source

, 1993
F. C. Sze
openalex   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

Understanding the Dissolution Kinetics of a DINCH Plasticized PVC: Experimental Design and Applied Modeling. [PDF]

ChemSusChem
Denolf R, Doolaege JC, Selmurzaeva E, Manhaeghe D, De Somer T, Haris M, Vermeeren N, Kol R, Hogie J, De Meester S.   +9 more
europepmc   +1 more source

A Tire Performance Evaluation Method by the Use of Experimental Design and Magic Formula

, 2005
Katsunori Tanaka, Shinichi Morita
openalex   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi   +13 more
wiley   +1 more source

Individual-Level Effects of a Digital Behavioural Treatment for Chronic Pain: Proof-of-Concept of a Single-Case Experimental Design Study. [PDF]

Eur J Pain
Al Sharaa H, Bartels SL, Taygar AS, Engman L, Petersson S, Flink I, Boersma K, McCracken LM, Simons L, Vlaeyen JWS, Onghena P, Wicksell RK.   +11 more
europepmc   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source

Optimization by the 4S Sequential Experimental Design Process of a Competitive Lateral Flow Immunoassay Device for the Detection of Aflatoxin B1. [PDF]

Toxins (Basel)
Cavalera S, Stanzani S, Serra T, Testa V, Di Nardo F, Baggiani C, Anfossi L.   +6 more
europepmc   +1 more source